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1. Introduction 
Epidermal growth factor (EGF) binds to specific 
plasma membrane receptors and stimulates growth 
and proliferation in a wide variety of cells in culture 
(review [ 1 I). There is increasing evidence to suggest 
that the liver is an important target tissue for EGF 
action. Thus, specific binding sites for EGF have been 
characterized in liver plasma membranes [2] and iso- 
lated hepatocytes (M. F. et al., submitted). Further- 
more, EGF is biologically active in hepatocytes. 
Indeed, a growth promoting effect of EGF has been 
demonstrated in neonatal [3] and adult [4,5] rat 
hepatocytes and intraperitoneal infusion of EGF has 
been reported to initiate hepatic DNA synthesis in 
vivo [6]. The effect of EGF on the initiation of DNA 
synthesis in liver cells was greatly amplified by the 
simultaneous presence of insulin and glucagon [3-61. 
Here, we have investigated the effects of EGF, 
insulin and glucagon used individually or in combina- 
tion, on amino acid transport in monolayer cultures 
of adult rat hepatocytes. While insulin and glucagon 
displayed additive stimulatory effects, EGF by itself 
had no significant effect on amino acid transport. 
The unexpected and intriguing finding was that EGF 
strongly inhibited the glucagon stimulation of amino 
acid transport but failed to affect the insulin stimu- 
latory effect. 
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2. Materials and methods 
Hepatocytes, isolated from adult male Wistar rats 
as in [7] were allowed to plate on collagen-precoated 
culture dishes for 4 h at 37°C in Waymouth’s medium 
in the presence of 10% fetal calf serum [8]. After the 
attachment period, the medium was replaced with 
Waymouth’s medium, without serum, containing 
0.2% defatted bovine serum albumin (BSA). Mono- 
layer cultures were incubated at 37°C for an addi- 
tional 20 h. Antibiotics (penicillin, 100 units/ml and 
streptomycin, 100 pg/ml) were continuously present 
in Waymouth’s media. 
For transport studies, cells were washed 3 times 
with 2 ml Krebs-Ringer bicarbonate (KRB) buffer 
and incubated in 0.9 ml of KRB buffer containing 1% 
defatted BSA, bacitracin (0.8 mg/ml) and gentamycin 
(50 pg/ml), in the absence or presence of hormones 
for 3 h at 37°C. At the end of the incubation period, 
transport assays were initiated by adding 0.1 ml of 
KRB buffer containing a-amino [ 14C] isobutyrate 
([ 14C]AIB) (0.2 &i, 0.1 mM final cont.) and [3H]- 
inulin (1 PCi). After 15 min the reaction was termi- 
nated by aspirating the radioactive medium and by 
washing the cells 3 times with 2 ml chilled KRB 
buffer. The cells were digested with 0.5 ml 0.2 N 
NaOH and counted for 14C and 3H. The transport 
data were corrected for extracellular trapping, and 
normalized per mg protein. 
Porcine monocomponent insulin and highly puri- 
fied porcine glucagon were gifts from Novo; epidermal 
growth factor was purchased from Collaborative Res. 
3. Results 
The effects of insulin, glucagon, dibutyryl cyclic 
AMP (Bt,cAMP), and EGF on AIB transport were 
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Table 1 
Effects of insulin, glucagon, B&CAMP and EGF on Lu-aminoisobutyrate (AIB) 
transport in primary cultures of rat hepatocytes 
___.__. 
Basal 
Insulin 
Glucagon 
Bt,cAMP 
EGF 
AIB influx % Increase 
(nmol . mg.protein’ . 15 mm-‘) above basal 
_-. 
(n = 8) 0.67 i 0.11 - 
(n = 5) 2.41 F 0.21 260 
(n = 8) 3.60 F 0.48 437 
(n =5) 360 * 0.72 437 
(n = 8) 0.78 i 0.28 16 
Insulin + EGF (n=S) 2.82 i 0.39 321 
Glucagon + EGF (n = 8) 1.45 i 0.18 116 
Bt,cAMP + EGF (n = 5) 1.53 f 0.21 128 
InsuIm + glucagon (n =5) 4.71 i 0.39 603 
Insulin + 
glucagon + EGF (n = 5) 2.78 + 0.54 314 
12 11 10 9 8 7 
[EGF] , -10gM 
Monolayers of rat hepatocytes were incubated for 3 h at 37°C without (basal) or 
with 10 nM insulin, 100 nM glucagon, 10 PM Bt,cAMP or 1 nM EGF, used alone 
or in combination. The influx of 0.1 mM [??]AIB was then measured over a 15 
min period. Each value represents the mean i: SE of n separate xpt. 
Fig.1, Dose dependence of the effect of EGF on the stimulator-y effect of glucagon on a-aminoisobutyrate transport. Monolayers 
were incubated for 3 h at 37°C with varying concentrations of EGF (0.01-100 nM) in the presence of 100 nM glucagon. The 
uptake of 0.1 mM a-amino[‘4Cjisobutyrate was then measured over a 15 min period. Results are expressed as the percentage of 
maximal glucagon stimu~tion. Each point represent he mean f SE of 3 separate xpt. 
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investigated in primary cultures of rat hepatocytes 
after a 3 h exposure to each agent used alone or in 
combination. As reported, insulin [S,9) and glucagon 
[9] were found to stimulate AIB transport in primary 
cultures of hepatocytes by 260% and 440%, respec- 
tively (table 1). EGF (1 nM) had no significant effect 
on AIB transport. Raising the concentration of EGF 
to 1 PM did not affect AIB transport, either in mono- 
layer cultures or in fresh suspensions of rat hepatocytes 
(not shown). However, EGF strongly inhibited the 
glucagon-induced stimulation of AIB transport, and 
was without effect on the stimulation of amino acid 
transport by insulin (table 1). Consistent with this 
finding, we observed that EGF also inhibited the 
effect of BtzcAMP. 
As observed in freshly isolated hepatocytes [7], 
insulin and glucagon exerted additive effect on A!B 
transport in primary cultured hepatocytes (table 1). 
Interestingly, the inhibitory effect of EGF on the 
glucagon-stimulated AIB transport persisted in the 
presence of insulin (table 1). 
The dose-dependence of the inhibitory effect of 
EGF on the glucagon stimulation of AIB transport 
is shown in fig. 1. The inhibitory effect of EGF could 
be detected at as low as 0.01 nM peptide. The half- 
maximal inhibition occurred with EGF at 0.067 + 
0.018 nM (n = 3), and maximal effect (-85% inhibi- 
tion) was observed with EGF at 1 nM. With greater 
concentrations of EGF (4-100 nM), this inhibition 
was slightly reduced (fig.1). 
4, Discussion 
We have shown here that EGF selectively inhibits 
the glucagon stimulation of amino acid transport in 
primary cultured rat hepatocytes. The observation 
that EGF inhibits the CAMP stimulatory effect as well 
as the glucagon effect, along with the fact that EGF 
does not inhibit glucagon binding in hepatocytes 
[lo], indicate that the inhibitory effect of EGF occurs 
at a post-receptor step of glucagon action. Glucagon 
stimulated amino acid transport in freshly isolated 
hepatocytes by inducing the synthesis of high af~nity 
carrier proteins which are not expressed under basal 
conditions [7]. In [9] glucagon stimulated amino acid 
transport in monolayer cultures of rat hepatocytes 
and this was also found to result from the synthesis 
of high affinity transport proteins (0. M., unpublished). 
Many intracellular events are likely to occur between 
the transient raise in intracellular CAMP induced by 
glucagon and the synthesis of specific proteins. The 
identi~cation of the step(s) affected by EGF could 
shed some light on the mechanism of action of this 
peptide on the control of protein synthesis. 
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